Overview
Dan Longrois practices in Paris, France. Mr. Longrois is rated as a Distinguished expert by MediFind in the treatment of Low Blood Pressure. His top areas of expertise are Delirium Tremens, Low Blood Pressure, Anaphylaxis, Lung Transplant, and Heart Bypass Surgery.
His clinical research consists of co-authoring 162 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles in the study of Low Blood Pressure.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Delirium TremensMr. Longrois isDistinguished. Learn about Delirium Tremens.
- Low Blood PressureMr. Longrois isDistinguished. Learn about Low Blood Pressure.
- Advanced
- AnaphylaxisMr. Longrois isAdvanced. Learn about Anaphylaxis.
- VasoconstrictionMr. Longrois isAdvanced. Learn about Vasoconstriction.
- Experienced
- Acute PainMr. Longrois isExperienced. Learn about Acute Pain.
- Acute Respiratory Distress Syndrome (ARDS)Mr. Longrois isExperienced. Learn about Acute Respiratory Distress Syndrome (ARDS).
- Cardiogenic ShockMr. Longrois isExperienced. Learn about Cardiogenic Shock.
- Cerebral HypoxiaMr. Longrois isExperienced. Learn about Cerebral Hypoxia.
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19Mr. Longrois isExperienced. Learn about COVID-19.